![Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1603802575/CovanceEvansville_3.jpg/CovanceEvansville_3.jpg?VersionId=ys40sTg3ReHX6gYsZ1IYZwPtUCZAVwJR)
Covance starting to rebound, but clinical trial business still being hit by COVID-19 | Fierce Biotech
![LabCorp to Acquire Covance for Approximately $6.1 Billion, Creating World's Leading Healthcare Diagnostics Company - New Jersey Business Magazine LabCorp to Acquire Covance for Approximately $6.1 Billion, Creating World's Leading Healthcare Diagnostics Company - New Jersey Business Magazine](https://njbmagazine.com/wp-content/uploads/2014/11/461252089-775x500.jpg)
LabCorp to Acquire Covance for Approximately $6.1 Billion, Creating World's Leading Healthcare Diagnostics Company - New Jersey Business Magazine
![Covance (NYSE: CVD) shareholders to vote on acquisition by LabCorp (NYSE: LH) (Laboratory Corp. of America) - Triad Business Journal Covance (NYSE: CVD) shareholders to vote on acquisition by LabCorp (NYSE: LH) (Laboratory Corp. of America) - Triad Business Journal](http://media.bizj.us/view/img/2427011/labcorpsign3000x2000*1200xx3000-1691-0-171.jpg)
Covance (NYSE: CVD) shareholders to vote on acquisition by LabCorp (NYSE: LH) (Laboratory Corp. of America) - Triad Business Journal
![An Overview of Covance CRO Clinical Research I Covance Clinical Trials — Clinical Research Certification An Overview of Covance CRO Clinical Research I Covance Clinical Trials — Clinical Research Certification](https://images.squarespace-cdn.com/content/v1/56a042fb25981d9326c9bbdb/1595859656245-785LQPKHKHAOXLP2LZ9A/image-asset.jpeg?format=2500w)